Related Experiment Video
Updated: Aug 14, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Robot-Assisted Radical Prostatectomy in Solid Organ Transplant Recipients: Initial Experience and Systematic Review
Wojciech Połom1, Sławomir Lizakowski2, Katarzyna Skrobisz3
1Department of Urology, Medical University of Gdańsk, 80-214 Gdańsk, Poland.
Cancers
|August 13, 2026
Summary
Robot-assisted radical prostatectomy using indocyanine green (ICG) fluorescence and the CMR Versius platform is feasible in solid organ transplant recipients. This technique aids in identifying transplanted ureters and mapping renal grafts during prostate cancer surgery.
Area of Science:
- Urology
- Surgical Oncology
- Transplant Surgery
Background:
- Prostate cancer is a common malignancy in male solid organ transplant recipients (SOTRs).
- Radical prostatectomy in SOTRs presents technical challenges due to prior surgeries and graft proximity.
- Novel techniques are needed to improve safety and outcomes for SOTRs undergoing prostatectomy.
Purpose of the Study:
- To report the first use of indocyanine green (ICG) fluorescence for ureter identification and graft vascular mapping during robot-assisted radical prostatectomy (RARP) in SOTRs.
- To document the initial experience with the CMR Versius platform in a SOTR undergoing RARP.
- To evaluate the feasibility and safety of these combined techniques in a small cohort of SOTRs.
Main Methods:
- Retrospective case series of four male SOTRs (two renal, two hepatic) undergoing RARP.
- Utilized a dual-route ICG protocol for intraureteral and intravenous administration for ureter identification and graft perfusion mapping.
- One patient underwent RARP using the CMR Versius robotic system with a modified port placement.
Main Results:
- All four RARP procedures were completed robotically without conversion.
- Median operative time was 176 minutes with median estimated blood loss of 350 mL.
- Negative surgical margins (R0) were achieved in all patients; no graft dysfunction occurred. One patient experienced a Clavien-Dindo IIIa complication.
Conclusions:
- Indocyanine green-guided RARP and the CMR Versius platform are technically feasible in carefully selected SOTRs at experienced centers.
- No graft-related complications were observed in this initial series.
- Larger, multicenter studies are required to validate the safety and oncological efficacy of these approaches.